{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:00:08Z","timestamp":1792051208343,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022840","name":"Serum Institute of India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022840","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jim.2024.113769","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T18:09:55Z","timestamp":1729620595000},"page":"113769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development of an ELISA for an effective potency determination of recombinant rabies human monoclonal antibody"],"prefix":"10.1016","volume":"534","author":[{"given":"Ambika","family":"Divase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambhaji","family":"Pisal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjusha","family":"Dake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Dhere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin Kumar","family":"Dakshinamurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peddireddy Srinivas","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrashekhar","family":"Kamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Digamber Singh","family":"Chahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanta","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelu","family":"Nawani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jim.2024.113769_bb0005","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants","volume":"79","author":"Bakker","year":"2005","journal-title":"J. Virol. [Internet]"},{"issue":"1\u20133","key":"10.1016\/j.jim.2024.113769_bb0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0147-9571(82)90040-6","article-title":"Purification, concentration and evaluation of rabies virus antigen","volume":"5","author":"Barth","year":"1982","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"issue":"4","key":"10.1016\/j.jim.2024.113769_bb0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(88)90185-5","article-title":"NIH test, a problematic method for testing potency of inactivated rabies vaccine","volume":"6","author":"Barth","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2024.113769_bb0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biologicals.2017.02.002","article-title":"G-protein based ELISA as a potency test for rabies vaccines","volume":"46","author":"Chabaud-Riou","year":"2017","journal-title":"Biologicals"},{"issue":"1","key":"10.1016\/j.jim.2024.113769_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2003.12.001","article-title":"Development of a qualitative indirect ELISA for the measurement of rabies virus-specific antibodies from vaccinated dogs and cats","volume":"117","author":"Cliquet","year":"2004","journal-title":"J. Virol. Methods"},{"issue":"1","key":"10.1016\/j.jim.2024.113769_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1099\/0022-1317-59-1-197","article-title":"A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application for potency tests of vaccines against rabies","volume":"59","author":"Ferguson","year":"1982","journal-title":"J. General Virol. [Internet]"},{"issue":"12","key":"10.1016\/j.jim.2024.113769_bb0035","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2024.113769_bb0040","series-title":"Rabies. Vol. 3, Nature Reviews Disease Primers","author":"Fooks","year":"2017"},{"issue":"1","key":"10.1016\/j.jim.2024.113769_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1045-1056(02)00070-2","article-title":"Inactivated rabies vaccine control and release:use of an ELISA method","volume":"31","author":"Fournier-Caruana","year":"2003","journal-title":"Biologicals"},{"issue":"8","key":"10.1016\/j.jim.2024.113769_bb0050","first-page":"1857","article-title":"A novel ELISA for quantification of glycoprotein in human rabies vaccines using a clinically proven virus neutralizing human monoclonal antibody","volume":"16","author":"Gairola","year":"2020"},{"issue":"126","key":"10.1016\/j.jim.2024.113769_bb0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijid.2022.10.046","article-title":"Global burden of rabies in 204 countries and territories, from 1990 to 2019: results from the global burden of disease study 2019","author":"Gan","year":"2023","journal-title":"Int. J. Infect. Dis."},{"issue":"50","key":"10.1016\/j.jim.2024.113769_bb0060","doi-asserted-by":"crossref","first-page":"6022","DOI":"10.1016\/j.vaccine.2013.10.019","article-title":"A relevant in vitro ELISA test in alternative to the in vivo NIH test for human rabies vaccine batch release","volume":"31","author":"Gibert","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jim.2024.113769_bb0065","first-page":"196","article-title":"Safety of new indigenous human rabies monoclonal antibody (RmAb) for post exposure prophylaxis","volume":"30","author":"Huluvadi Shivalingaiah","year":"2018","journal-title":"iapsmupuk.org [Internet]"},{"issue":"159","key":"10.1016\/j.jim.2024.113769_bb0070","first-page":"e59641","article-title":"In vitro ELISA test to evaluate rabies vaccine potency","volume":"2020","author":"Jallet","year":"2020","journal-title":"JoVE (J. Visualiz. Exp.) [Internet]"},{"issue":"23","key":"10.1016\/j.jim.2024.113769_bb0075","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1016\/j.vaccine.2010.03.039","article-title":"The immune response to rabies virus infection and vaccination","volume":"28","author":"Johnson","year":"2010","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.jim.2024.113769_bb0080","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taab060","article-title":"Diagnostic accuracy of ELISA kits for measurement of rabies antibodies","volume":"28","author":"Ling","year":"2021","journal-title":"J. Travel Med."},{"key":"10.1016\/j.jim.2024.113769_bb0085","series-title":"Measures of Rabies Immunity. Rabies: Scientific Basis of the Disease and its Management","first-page":"445","author":"Moore","year":"2020"},{"issue":"4","key":"10.1016\/j.jim.2024.113769_bb0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biologicals.2005.06.005","article-title":"The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays","volume":"33","author":"Moore","year":"2005","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.jim.2024.113769_bb0095","article-title":"Rabies virus antibodies from oral vaccination as a correlate of protection against lethal infection in wildlife","volume":"2","author":"Moore","year":"2017","journal-title":"Trop Med. Infect. Dis."},{"issue":"3","key":"10.1016\/j.jim.2024.113769_bb0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/tropicalmed2030031","article-title":"Rabies virus antibodies from oral vaccination as a correlate of protection against lethal infection in wildlife","volume":"2","author":"Moore","year":"2017","journal-title":"Trop. Med. Infect. Disease"},{"issue":"8","key":"10.1016\/j.jim.2024.113769_bb0105","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3390\/v13081516","article-title":"Challenges of rabies serology: defining context of interpretation","volume":"13","author":"Moore","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jim.2024.113769_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/ANTI.S33533","article-title":"Monoclonal antibodies for the prevention of rabies: theory and clinical practice","author":"Nagarajan","year":"2014","journal-title":"Antibody Technol. J."},{"issue":"1","key":"10.1016\/j.jim.2024.113769_bb0115","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jmv.1890090107","article-title":"Enzyme-linked lmmunosorbent assay: a rapid reproducible test for the measurement of rabies antibody","volume":"9","author":"Nicholson","year":"1982","journal-title":"J. Med. Virol. [Internet]"},{"issue":"8","key":"10.1016\/j.jim.2024.113769_bb0120","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1128\/CVI.00204-10","article-title":"Recombinant diabody-based immunocapture enzyme-linked immunosorbent assay for quantification of rabies virus glycoprotein","volume":"17","author":"Nimmagadda","year":"2010","journal-title":"Clin. Vaccine Immunol. [Internet]"},{"issue":"4","key":"10.1016\/j.jim.2024.113769_bb0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/1045-1056(90)90037-Z","article-title":"In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody","volume":"18","author":"Perrin","year":"1990","journal-title":"Biologicals"},{"issue":"6","key":"10.1016\/j.jim.2024.113769_bb0130","first-page":"629","article-title":"Current status of human rabies prevention: remaining barriers to global biologics accessibility and disease elimination","volume":"18","author":"Rupprecht","year":"2019"},{"issue":"1","key":"10.1016\/j.jim.2024.113769_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-022-00470-4","article-title":"Development of functionally relevant potency assays for monovalent and multivalent vaccines delivered by evolving technologies","volume":"7","author":"Sanyal","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"3","key":"10.1016\/j.jim.2024.113769_bb0140","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/jvi.53.3.926-934.1985","article-title":"Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein","volume":"53","author":"Seif","year":"1985","journal-title":"J. Virol. [Internet]"},{"key":"10.1016\/j.jim.2024.113769_bb0145","article-title":"Awareness on rabies and its prevention among anganwadi workers","volume":"7","author":"Shivalingaiah Anwith","year":"2018","journal-title":"researchgate.net [Internet]"},{"issue":"3","key":"10.1016\/j.jim.2024.113769_bb0150","article-title":"Comparison of a micro-neutralization test with the rapid fluorescent focus inhibition test for measuring rabies virus neutralizing antibodies","volume":"2","author":"Smith","year":"2017","journal-title":"Trop Med. Infect. Dis."},{"key":"10.1016\/j.jim.2024.113769_bb0155","article-title":"A rapid reproducible test for determining rabies neutralizing antibody","volume":"48","author":"Smith","year":"1973","journal-title":"Bull. Org. Mond. Sant. Bull. Wid Hith Org"},{"key":"10.1016\/j.jim.2024.113769_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2020.112939","article-title":"Development of competitive inhibition ELISA as an effective potency test to analyze human rabies vaccines and assessment of the antigenic epitope of rabies glycoprotein","volume":"492","author":"Soni","year":"2021","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jim.2024.113769_bb0165","series-title":"WHO expert committee on biological standardization: fifty-sixth report [Internet]","author":"Standardization WEC on B","year":"2007"},{"issue":"4","key":"10.1016\/j.jim.2024.113769_bb0170","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0092-1157(89)80001-0","article-title":"Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera","volume":"17","author":"Thraenhart","year":"1989","journal-title":"J. Biol. Stand."},{"key":"10.1016\/j.jim.2024.113769_bb0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.biologicals.2019.05.004","article-title":"Potency test to discriminate between differentially over-inactivated rabies vaccines: agreement between the NIH assay and a G-protein based ELISA","volume":"60","author":"Toinon","year":"2019","journal-title":"Biologicals"},{"key":"10.1016\/j.jim.2024.113769_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2022.101833","article-title":"Robust humoral immune response against rabies virus in rabbits and guinea pigs immunized with plasmid DNA vectors encoding rabies virus glycoproteins \u2013 an approach to the production of polyclonal antibody reagents","volume":"64","author":"Volokhov","year":"2022","journal-title":"Mol. Cell. Probes"},{"issue":"1","key":"10.1016\/j.jim.2024.113769_bb0185","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jviromet.2011.10.019","article-title":"Evaluation of ELISA for detection of rabies antibodies in domestic carnivores","volume":"179","author":"Wasniewski","year":"2012","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jim.2024.113769_bb0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jviromet.2016.10.006","article-title":"First international collaborative study to evaluate rabies antibody detection method for use in monitoring the effectiveness of oral vaccination programmes in fox and raccoon dog in Europe","volume":"238","author":"Wasniewski","year":"2016","journal-title":"J. Virol. Methods"},{"issue":"4","key":"10.1016\/j.jim.2024.113769_bb0195","first-page":"570","article-title":"Early diagnosis of rabies by mouse inoculation. Measurement of humoral immunity to rabies by mouse protection test","volume":"32","author":"Webster","year":"1935"},{"key":"10.1016\/j.jim.2024.113769_bb0200","author":"WHO Expert Consultation on Rabies"},{"issue":"41","key":"10.1016\/j.jim.2024.113769_bb0210","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1016\/j.vaccine.2019.08.043","article-title":"Rabies virus glycoprotein serology ELISA for measurement of neutralizing antibodies in sera of vaccinated human subjects","volume":"37","author":"Zhao","year":"2019","journal-title":"Vaccine"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175924001546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175924001546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T21:39:26Z","timestamp":1732138766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175924001546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":41,"alternative-id":["S0022175924001546"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2024.113769","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an ELISA for an effective potency determination of recombinant rabies human monoclonal antibody","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2024.113769","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113769"}}